Correlation Between Sprott Focus and Santen Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sprott Focus and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprott Focus and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprott Focus Trust and Santen Pharmaceutical Co, you can compare the effects of market volatilities on Sprott Focus and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprott Focus with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprott Focus and Santen Pharmaceutical.

Diversification Opportunities for Sprott Focus and Santen Pharmaceutical

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Sprott and Santen is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Sprott Focus Trust and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and Sprott Focus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprott Focus Trust are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of Sprott Focus i.e., Sprott Focus and Santen Pharmaceutical go up and down completely randomly.

Pair Corralation between Sprott Focus and Santen Pharmaceutical

Given the investment horizon of 90 days Sprott Focus Trust is expected to under-perform the Santen Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Sprott Focus Trust is 1.31 times less risky than Santen Pharmaceutical. The stock trades about -0.3 of its potential returns per unit of risk. The Santen Pharmaceutical Co is currently generating about -0.22 of returns per unit of risk over similar time horizon. If you would invest  1,115  in Santen Pharmaceutical Co on October 7, 2024 and sell it today you would lose (62.00) from holding Santen Pharmaceutical Co or give up 5.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sprott Focus Trust  vs.  Santen Pharmaceutical Co

 Performance 
       Timeline  
Sprott Focus Trust 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sprott Focus Trust has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Sprott Focus is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Santen Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Santen Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Sprott Focus and Santen Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sprott Focus and Santen Pharmaceutical

The main advantage of trading using opposite Sprott Focus and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprott Focus position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.
The idea behind Sprott Focus Trust and Santen Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets